Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
90.81
-0.79 (-0.86%)
At close: Aug 17, 2026, 4:00 PM EDT
90.81
0.00 (0.00%)
After-hours: Aug 17, 2026, 6:30 PM EDT

Edwards Lifesciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
52,34349,47143,66346,24646,12880,883
Market Cap Growth
14.77%13.30%-5.58%0.25%-42.97%42.25%
Enterprise Value
48,76646,32339,98245,14245,07779,772
Last Close Price
90.8185.2574.0376.2574.61129.55
PE Ratio
54.1846.0810.4632.9830.3153.81
Forward PE
28.9230.9331.1928.4130.3552.98
PS Ratio
8.048.158.039.2310.3315.46
PB Ratio
4.934.794.346.887.9413.86
P/TBV Ratio
7.196.656.209.0610.5918.62
P/FCF Ratio
36.5137.06150.6171.9447.3857.51
P/OCF Ratio
30.4331.0180.5151.6337.8746.70
PEG Ratio
2.383.243.692.772.953.38
EV/Sales Ratio
7.497.637.359.0110.1015.25
EV/EBITDA Ratio
24.4225.8124.6228.0526.8146.34
EV/EBIT Ratio
26.6328.2827.0030.3529.2450.28
EV/FCF Ratio
34.0234.70137.9270.2346.3056.73
Debt / Equity Ratio
0.070.070.070.100.120.12
Debt / EBITDA Ratio
0.350.390.420.420.400.39
Debt / FCF Ratio
0.490.532.421.070.710.49
Net Debt / Equity Ratio
-0.33-0.34-0.33-0.14-0.09-0.13
Net Debt / EBITDA Ratio
-1.79-1.97-2.02-0.59-0.31-0.45
Net Debt / FCF Ratio
-2.49-2.64-11.32-1.47-0.54-0.55
Asset Turnover
0.480.450.490.570.530.67
Inventory Turnover
1.271.211.121.100.901.63
Quick Ratio
3.452.833.132.061.872.07
Current Ratio
4.523.724.183.383.033.08
Return on Equity (ROE)
9.18%10.35%16.64%19.48%22.74%28.88%
Return on Assets (ROA)
8.37%7.65%8.26%10.53%11.47%12.60%
Return on Invested Capital (ROIC)
17.39%19.98%21.26%23.92%25.98%31.39%
Return on Capital Employed (ROCE)
14.80%13.80%12.80%18.20%21.20%21.20%
Earnings Yield
1.92%2.17%9.56%3.03%3.30%1.86%
FCF Yield
2.74%2.70%0.66%1.39%2.11%1.74%
Buyback Yield / Dilution
1.64%2.25%1.66%2.37%1.11%0.11%
SEC Filings: 10-K · 10-Q